Navigation Links
New book offers cutting-edge perspective on causes of schizophrenia; related disorders

BINGHAMTON, NY About 1 in 10 people have the potential to develop schizophrenia, but only 1 in 100 actually end up with this devastating illness. The challenge is in knowing why some do and some don't.

Drawing from over 25 years of laboratory study, Mark F. Lenzenweger, a distinguished professor of clinical science, neuroscience and cognitive psychology at Binghamton University, thinks that not only does he have the makings of a good response to this troubling question but also how to go about finding those answers.

In his latest book, Schizotypy and Schizophrenia: The View from Experimental Psychopathology, Lenzenweger explores lessons he has learned in the psychological science laboratory while probing the broader questions of how to think about and conduct psychopathology research.

"The liability for schizophrenia is relatively prevalent and common in our population," said Lenzenweger. "Therefore, understanding why someone goes on to develop the illness is a high priority research question. I firmly believe that those who harbor this liability but do not develop the full-blown illness of schizophrenia may hold the key to this puzzle. Since this is an ongoing challenge for our society, training the next generation in how to think about and conduct psychopathology research is just as vital. So what I've tried to do is combine both of those elements in a way that I hope will appeal to both the experienced research and those just starting out."

The book traces Lenzenweger's intense efforts to find answers using laboratory and statistical procedures by examining a host of related conceptual issues, data analytic strategies and methodical viewpoints that he has found helpful over the years. Using clinical anecdotes and research recollection, Lenzenweger hopes that readers will develop an appreciation for those substantive issues that have and are currently pressing (and interesting) on the causes of schizophrenia and related disorders.

"Schizophrenia is perhaps the costliest form of mental illness," said Lenzenweger. "In addition, it has a strong genetic component; about 80 percent of what determines schizophrenia is related to genetic influences. All people with schizophrenia share a personality organization known as schizotypy. And the person who carries shizotypy is known as a schizotype. Yet not all schizotypes are schizophrenic. In fact, the vast majority of schizotypes do not go on to develop the illness. So it stands to reason that the study of schizotypic individuals offers a unique perspective on what might cause the illness."

According to Lenzenweger, the way forward in understanding the causes and development of schizophrenia will be complex and difficult terrain.

"There will be no simple solution or discovery the remedies the entire problem," said Lenzenweger. "But I hope that my book will chart the course for the field as it stands currently and show the way forward for the generation to come."


Contact: Gail Glover
Binghamton University

Related medicine news :

1. Natural Cosmetic Company Offers Women Entrepreneurs a New Way to Make Money in Hard Times
2. Scripps Center for Executive Health Now Offers Genetic Testing
3. Apriori Beauty Offers Free Anti-Aging Product Upgrade
4. Health Literacy Innovations Announces 1st Annual Health Literacy Innovator Award — Anonymous Donor Offers Prize Money To Winners
5. Obesity in America: World-Renowned Health Educator Offers Solutions to Obesity Epidemic
6. Angel MedFlight Worldwide Air Ambulance offers $3,000 scholarship for a student pursuing a career in aviation at an Arizona school
7. Beverly Hills Aesthetics Offers Revolutionary New Celluraze Procedure
8. Innovative Fitness Machine Offers a Low-impact, High-intensity Workout
9. ConnectedIn Divorce Resource Offers Online Expert Website for People Considering or Going Through Divorce
10. PBG Offers a Pre-Upgrade Site Survey for Ericom, VMware, and NetApp Upgrades
11. AAP Offers New Online Pediatric Symptom Checker on
Post Your Comments:
Related Image:
New book offers cutting-edge perspective on causes of schizophrenia; related disorders
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, ... the womb. "My last baby had high blood pressure due to loud noises," she ... protect their babies from noise pollution as well as radio waves and microwaves." , ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... – Kreithen”), one of the leading plastic surgery practices in Florida, is proud ... chosen to consult for surgical innovations giant Ethicon Inc., a Johnson & Johnson ...
(Date:11/30/2015)... Morton Grove, IL (PRWEB) , ... November 30, 2015 , ... ... milestone for an emerging pharmaceutical company. Because it is so important to this key ... titled “Success Factors in your IND Filing” on December 4th at 11am EST. , ...
(Date:11/30/2015)... ... 30, 2015 , ... Healthjump, Inc. announced that it has ... consulting, development and support company. The purchase will expand the capability to serve ... extend the services currently provided by Healthjump. , Through this purchase, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BOSTON , Nov. 30, 2015  Kevin ... of Sensium Healthcare, a global pioneer in wireless ... Boston, MA , Mr. Smith ... of Sensium,s global commercial strategy.  He will also ... universities, to build clinical evidence for SensiumVitals, the ...
(Date:11/30/2015)... , Nov. 30, 2015  The fee-for-service ... in U.S. medical imaging is on its ... accountable care payer-provider contracts are set to ... their wake, alter provider-vendor relationships. The shift ... push forward new purchasing frameworks in the ...
(Date:11/30/2015)... WOODCLIFF LAKE, N.J. and SAN ... Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... (FDA) has accepted for filing the New Drug Application ... approved, the extended release formulation will offer patients a ... ® ) is currently approved as ...
Breaking Medicine Technology: